XELJANZ (Tofacitinib) Tablets
Description of Xeljanz (Tofacitinib)
Xeljanz is called a Janus kinase (JAK) inhibitor
Its use and Indications
Xeljanz is used to treat adults with moderately to severely active Rheumatoid Arthritis in which Methotrexate did not work well.
Xeljanz is not recommended for patients with severe Liver problems
Safety in children is yet to be established
Treatment related info
For treatment related information, please consult your treating Physician.
Xeljanz is provided as 5 mg tofacitinib (equivalent to 8 mg tofacitinib citrate) Tablets. White, round, immediate-release-film coated tablets, debossed with “Pfizer” on one side.
Xeljanz is supplied in bottles of 28, 60 and 180 Tablets.
Storage and handling
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
Do not repackage
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Pfizer Labs
Mob No: +91 7738100125, +91 7738151650
E Mail: email@example.com